SCHEMBL29816705

SCHEMBL29816705

CCCCCC(CC)NC(=O)C(=O)c1cn(C)c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
RAB9A P51151 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
CHRM2 P08172 2/20 0.47
ADRA2A P08913 2/20 0.47
CHRM1 P11229 2/20 0.47
ADRA2B P18089 2/20 0.47
CHRM3 P20309 2/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR4 Q13639 2/20 0.47
CYP1A2 P05177 1/20 0.47
CHRM4 P08173 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
HTR1D P28221 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4759431 0.74 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL14185947 0.74 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KMT2ANR4A2LMNA
SCHEMBL9520813 0.70 KDM4E (0.60) ALDH1A1KDM4EHTT
SCHEMBL14665132 0.70 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL13896419 0.70 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL11921550 0.70 RAB9A (0.69) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1
Hydrochloric Acid SCHEMBL9517585 0.70 KDM4E (0.59) ALDH1A1KDM4EHTT
SCHEMBL14745414 0.69 LMNA (0.71) ALDH1A1SMN1; SMN2KMT2ANR4A2LMNA
SCHEMBL14828742 0.68 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL1558956 0.68 POLB (0.68) ALDH1A1SMN1; SMN2RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114845717-A Treatment of schizophrenia disorders using combination therapy 剑桥认知有限公司 2022-08-02 CN claimed
CN-114845717-A Treatment of schizophrenia disorders using combination therapy 剑桥认知有限公司 2022-08-02 CN disclosed